Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 27:14:917706.
doi: 10.3389/fnagi.2022.917706. eCollection 2022.

Parkinsonian Syndromes in Motor Neuron Disease: A Clinical Study

Jacopo Pasquini  1   2   3 , Francesca Trogu  1   2 , Claudia Morelli  1 , Barbara Poletti  1 , Floriano Girotti  1 , Silvia Peverelli  1 , Alberto Brusati  1   4 , Antonia Ratti  1   5 , Andrea Ciammola  1 , Vincenzo Silani  1   6 , Nicola Ticozzi  1   6
Affiliations

Parkinsonian Syndromes in Motor Neuron Disease: A Clinical Study

Jacopo Pasquini et al. Front Aging Neurosci. .

Abstract

Background: Parkinsonian syndromes may rarely occur in motor neuron disease (MND). However, previous studies are heterogeneous and mostly case reports or small case series. Therefore, we aimed to identify and characterize patients with concurrent parkinsonian syndromes extracted from a cohort of 1,042 consecutive cases diagnosed with MND at a tertiary Italian Center.

Methods: Diagnosis of Parkinson's disease (PD), progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) was made according to current criteria. Clinical characterization included: upper and lower motor neuron disease features, typical and atypical parkinsonian features, oculomotor disorders, cognitive testing, MRI features, and, when available molecular neuroimaging. Genetic testing was carried out for major MND and PD-associated genes.

Results: Parkinsonian syndromes were diagnosed in 18/1042 (1.7%) of MND patients (7 PD, 6 PSP, 3 CBS, 2 other parkinsonisms). Based on phenotype, patients could be categorized into amyotrophic lateral sclerosis (ALS)-parkinsonism and primary lateral sclerosis (PLS)-parkinsonism clusters. Across the whole database, parkinsonism was significantly more common in PLS than in other MND phenotypes (12.1 vs. 1.1%, p = 5.0 × 10-10). MND patients with parkinsonian features had older age of onset, higher frequency of oculomotor disorders, cognitive impairment, and family history of parkinsonism or dementia. Two patients showed pathogenic mutations in TARDBP and C9orf72 genes.

Conclusion: Specific patterns in MND-parkinsonism were observed, with PLS patients often showing atypical parkinsonian syndromes and ALS patients more frequently showing typical PD. Systematic clinical, genetic, and neuropathologic characterization may provide a better understanding of these phenotypes.

Keywords: amyotrophic lateral sclerosis; motor neuron disease (MND); parkinsonism; primary lateral sclerosis (PLS); progressive supranuclear palsy.

PubMed Disclaimer

Conflict of interest statement

JP is the recipient of a European Academy of Neurology Research Fellowship grant. AR received research funding from AriSLA. VS received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb Srl, and Novartis Pharma AG. He receives or has received research support from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is on the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, and Frontiers in Neurology. NT received research funding from the Italian Ministry of Health and AriSLA. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow-chart showing database extraction and selection of patients with overlapping MND and primary parkinsonian syndromes.
See this image and copyright information in PMC

References

    1. Armstrong M. J., Litvan I., Lang A. E., Bak T. H., Bhatia K. P., Borroni B. (2013). Criteria for the diagnosis of corticobasal degeneration. Neurology. 80, 496–503. 10.1212/WNL.0b013e31827f0fd1 - DOI - PMC - PubMed
    1. Boeve B. F., Lang A. E., Litvan I. (2003). Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann. Neurol. 54, S15–S19. 10.1002/ana.10570 - DOI - PubMed
    1. Brait K., Fahn S., Schwarz G. A. (1973). Sporadic and familial parkinsonism and motor neuron disease. Neurology. 23, 990–1002. 10.1212/WNL.23.9.990 - DOI - PubMed
    1. Brettschneider J., Del Tredici K., Toledo J. B., van Vugt J. J. F. A., Hop P. J., Zwamborn R. A. J. (2013). Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 74, 20–38. 10.1002/ana.23937 - DOI - PMC - PubMed
    1. Brooks B. R., Miller R. G., Swash M., Munsat T. L. (2000). World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron. Disord. 1, 293–299. 10.1080/146608200300079536 - DOI - PubMed